LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 63.39 | 770.25 | 8603 | 9326 | 0.9225 | 0.9556 | MN20160304_L02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 63.39 | 770.25 | 8755 | 9326 | 0.9388 | 0.9652 | MN20160304_L02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 65.61 | 770.25 | 8780 | 9736 | 0.9018 | 0.9443 | MN20160304_L02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 65.61 | 770.25 | 9173 | 9736 | 0.9422 | 0.9677 | MN20160304_L02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 67.83 | 770.25 | 9110 | 10078 | 0.9039 | 0.9463 | MN20160304_L02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 67.83 | 770.25 | 9496 | 10078 | 0.9422 | 0.9682 | MN20160304_L02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 70.05 | 770.25 | 9254 | 10413 | 0.8886 | 0.9381 | MN20160304_L02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 70.05 | 770.25 | 9840 | 10413 | 0.9449 | 0.9701 | MN20160304_L02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 72.27 | 770.25 | 9374 | 10730 | 0.8736 | 0.9301 | MN20160304_L02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 72.27 | 770.25 | 9991 | 10730 | 0.9311 | 0.9628 | MN20160304_L02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 74.50 | 770.25 | 9565 | 10991 | 0.8702 | 0.9288 | MN20160304_L02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 74.50 | 770.25 | 10228 | 10991 | 0.9305 | 0.9628 | MN20160304_L02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 76.75 | 770.25 | 9666 | 11262 | 0.8582 | 0.9225 | MN20160304_L02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 76.75 | 770.25 | 10222 | 11262 | 0.9076 | 0.9505 | MN20160304_L02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 78.98 | 770.25 | 9764 | 11518 | 0.8477 | 0.9171 | MN20160304_L02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 78.98 | 770.25 | 10507 | 11518 | 0.9122 | 0.9535 | MN20160304_L02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 81.20 | 770.25 | 9838 | 11766 | 0.8361 | 0.9110 | MN20160304_L02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 81.20 | 770.25 | 10780 | 11766 | 0.9162 | 0.9560 | MN20160304_L02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 83.42 | 770.25 | 9899 | 12031 | 0.8227 | 0.9040 | MN20160304_L02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 83.42 | 770.25 | 10880 | 12031 | 0.9043 | 0.9499 | MN20160304_L02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 85.64 | 770.25 | 10032 | 12287 | 0.8165 | 0.9010 | MN20160304_L02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 85.64 | 770.25 | 10941 | 12287 | 0.8904 | 0.9428 | MN20160304_L02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 87.86 | 770.25 | 10088 | 12543 | 0.8043 | 0.8946 | MN20160304_L02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 87.86 | 770.25 | 11112 | 12543 | 0.8859 | 0.9407 | MN20160304_L02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 3.21 | 770.25 | 897 | 904 | 0.9916 | 0.9283 | MN20160304_L02 | C08 |